Life Science REIT PLC
LSE:LABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (15.9), the stock would be worth GBX71.32 (65% upside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 9.6 | GBX43.1 |
0%
|
| 3-Year Average | 15.9 | GBX71.32 |
+65%
|
| 5-Year Average | 15.9 | GBX71.32 |
+65%
|
| Industry Average | 0.1 | GBX0.3 |
-99%
|
| Country Average | 0 | GBX0.04 |
-100%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
L
|
Life Science REIT PLC
LSE:LABS
|
150.9m GBP | 9.6 | -4.9 | |
| US |
|
Welltower Inc
NYSE:WELL
|
153.2B USD | 34.9 | 108.8 | |
| US |
|
Ventas Inc
NYSE:VTR
|
41.7B USD | 21.7 | 166 | |
| US |
|
Omega Healthcare Investors Inc
NYSE:OHI
|
13.9B USD | 15.4 | 24.2 | |
| US |
H
|
Healthpeak Properties Inc
F:HC5
|
9.5B EUR | 11.9 | 159.4 | |
| US |
|
Physicians Realty Trust
NYSE:DOC
|
11.2B USD | 11.9 | 159.8 | |
| US |
C
|
CareTrust REIT Inc
NYSE:CTRE
|
8.8B USD | 19.9 | 27.5 | |
| BE |
|
Aedifica NV
XBRU:AED
|
6B EUR | 22.7 | 24.5 | |
| US |
|
Healthcare Realty Trust Inc
NYSE:HR
|
6.6B USD | 14.4 | -26.5 | |
| US |
H
|
Healthcare Trust Of America Inc
F:HT01
|
5.3B EUR | 17.4 | 66.4 | |
| US |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
5.2B USD | 14.9 | 33.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 664.3 |
Other Multiples
Life Science REIT PLC
Glance View
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.
